Related Experiment Videos

Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines

W G Fong1, P Liston, E Rajcan-Separovic

  • 1Department of Biochemistry, Microbiology, and Immunology, University of Ottawa, Ottawa, Ontario, K1H 8M5, Canada.

Genomics
|November 23, 2000
PubMed

Insights

XIAP-associated factor 1 (XAF1) antagonizes XIAP's anti-apoptotic function. Loss of XAF1 and high XIAP expression in cancer may promote cell survival by increasing XIAP's inhibitory effects on apoptosis.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Biology

Background:

  • X-linked inhibitor of apoptosis protein (XIAP) is a key regulator of programmed cell death, inhibiting caspases-3, -7, and -9.
  • XIAP-associated factor 1 (XAF1) was identified as a novel protein that antagonizes XIAP's function.

Purpose of the Study:

  • To isolate and characterize the human XAF1 gene.
  • To investigate the role of XAF1 in cancer by analyzing its gene locus, allelic loss, and RNA expression in cancer cell lines.

Main Methods:

  • Yeast two-hybrid screening to identify XAF1.
  • Fluorescence in situ hybridization (FISH) and YAC mapping to localize the xaf1 gene.
  • Microsatellite analysis and RNA expression profiling of NCI 60 cancer cell lines.

Main Results:

  • The human xaf1 gene spans seven exons and is located at chromosome 17p13.2.
  • Allelic loss of the xaf1 gene is prevalent in cancer cell lines.
  • Cancer cell lines show significantly lower XAF1 mRNA levels compared to normal liver, while XIAP mRNA levels are high.

Conclusions:

  • The xaf1 gene is frequently altered in cancer, exhibiting allelic loss and reduced expression.
  • A high XIAP to XAF1 expression ratio in cancer cells may confer a survival advantage by enhancing XIAP's anti-apoptotic activity.

Related Concept Videos